𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Spinal Cord Paralysis Following Sclerotherapy for Esophageal Varices

✍ Scribed by Ernest Seidman; Andrée M. Weber; Claude L. Morin; Roméo Ethier; Jacques B. Lamarche; Ara J. Guerguérian; Guy Geoffroy; Claude C. Roy


Publisher
John Wiley and Sons
Year
1984
Tongue
English
Weight
583 KB
Volume
4
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


A child with cryptogenic cirrhosis underwent a third session of elective sclerotherapy. Endoscopic therapy consisted of intravascular injection of ethanolamine oleate in varices newly developed at the midesophagus level. Irreversible paraplegia was documented within 8 hr postoperatively. Two years later she eventually died from gastrointestinal bleeding. Autopsy findings were compatible with an infarct of the spinal cord secondary to an occlusion of the anterior spinal artery. Various hypotheses which might explain the passage of the sclerosing material from the esophagus to the anterior spinal artery include: arterial occlusion secondary to venous thrombosis and spinal cord necrosis, accidental injection in an intercostal artery or azygous vein through the esophageal wall, the presence of a congenital arteriovenous fistula or the opening of arteriovenous shunt. Paravasal injection of dilute sclerosing agent might protect against this unusual but dramatic complication.


📜 SIMILAR VOLUMES


Sucralfate for the prevention of early r
✍ Rex J. Polson; David Westaby; Alexander E. S. Gimson; Peter C. Hayes; Anthony J. 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB

One hundred eighty patients with variceal bleeding and treated by long-term sclerotherapy were randomized into a prospective randomized controlled clinical trial to assess the efficacy of sucralfate in reducing the frequency of rebleeding from esophageal ulceration prior to variceal obliteration. Ov

Improved survival following injection sc
✍ David Westaby; Brian R. D. Macdougall; Roger Williams 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 363 KB

Long-term follow-up (median: 37 months; range: 19 to 68) of the 116 patients (66 sclerotherapy, 60 control group) entered into a controlled trial of endoscopic variceal sclerotherapy has shown a total of 18 deaths in the sclerotherapy group, including five from variceal bleeding compared with 32 dea